Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
115 participants
OBSERVATIONAL
2022-11-15
2023-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Data Collection Study of Raw Thermal Images for the Purpose of Developing a Device for Early Detection of Breast Cancer
NCT00821613
New Technique as an Additional Diagnostic Tool for Women Undergoing Neoadjuvant Therapy for Breast Cancer
NCT00566085
A Prospective Study to Evaluate Clinical Performance of Thermalytix in Detecting Breast Cancers
NCT04688086
Molecular Breast Imaging as a Screening Tool for Women With Dense Breasts
NCT00620373
Breast Mapping and Detection of Suspicious Breast Lesions Using Feminai
NCT07220863
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cohort 1: Biopsy
Subjects who are scheduled for biopsy will be enrolled.
Thermalytix
One-time Thermal imaging is performed for this cohort.
Cohort 2: Screening mammogram
Patients who underwent screening mammogram will be enrolled.
Thermalytix
One-time Thermal imaging is performed for this cohort.
Cohort 3: Diganostic mammogram
Subjects scheduled for diagnostic mammogram will be enrolled.
Thermalytix
One-time Thermal imaging is performed for this cohort.
Cohort 4: Prior history of lympectomy, routine mammogram
Subjects with prior history of lumpectomy scheduled for their routine mammogram will be enrolled.
Thermalytix
One-time Thermal imaging is performed for this cohort.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Thermalytix
One-time Thermal imaging is performed for this cohort.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Be capable of signing and providing written consent in accordance with institutional and federal guidelines
* Be willing and able to comply with scheduled visits, treatment plan, and follow up with research staff
* Age ≥ 21 years
* Cohort specific criteria
* Cohort 1: Be scheduled for biopsy
* Cohort 2: Had a normal screening mammogram within 3 months of study enrollment
* Cohort 3: Be scheduled for diagnostic mammogram
* Cohort 4: History of breast cancer, s/p lumpectomy and be scheduled for routine mammogram
Exclusion Criteria
* Cohort 1: Previous biopsies in the same or opposite breast within 3 months of study enrollment, prior history of breast cancer, prior history of breast surgeries including implants
* Cohort 2: prior history of breast surgeries including implants
* Cohort 3: Already underwent a biopsy in the same or opposite breast within 3 months of study enrollment, prior history of breast cancer, prior history of breast surgeries including implants
* Cohort 4: surgery \<1 year, h/o mastectomy with reconstruction
* Unable to complete study related procedures
21 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Arizona
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pavani Chalasani, MD
Role: PRINCIPAL_INVESTIGATOR
University of Arizona
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Arizona Cancer Center
Tucson, Arizona, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY00001233
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.